Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092952604> ?p ?o ?g. }
- W2092952604 endingPage "309" @default.
- W2092952604 startingPage "302" @default.
- W2092952604 abstract "Clobazam (CLB) is a 1,5-benzodiazepine with antiepileptic properties. More than 70% of administered CLB is dealkylated to yield N-desmethylclobazam (N-CLB), a pharmacologically active metabolite, by cytochrome P450 (CYP) 3A4 and CYP2C19. The subsequent inactivation of N-CLB is primarily catalyzed by CYP2C19. Meanwhile, P450 oxidoreductase (POR) is the obligatory electron donor to all microsomal CYP enzymes. The aim of this study was to evaluate the impact of the CYP2C19 and POR genotypes on the pharmacokinetic parameters of CLB and N-CLB.This retrospective study included 85 Japanese patients with epilepsy who were treated with CLB. CYP2C19*2, *3, and P450 oxidoreductase (POR) *28 (rs1057868C>T) polymorphisms were evaluated. A total of 128 steady-state concentrations for both CLB and N-CLB were collected from the patients. A nonlinear mixed-effects model identified the pharmacokinetics of CLB and N-CLB; the covariates included CYP2C19 and POR genotypes, weight, gender, daily CLB dose, and coadministered antiepileptic drugs.Among the 85 patients, the allele frequencies of CYP2C19*2, CYP2C19*3, and POR*28 were 27.6%, 12.9%, and 41.2%, respectively. A one-compartment model with first-order absorption and/or elimination showed that the clearance of CLB and N-CLB was significantly lower by 18.1% and 84.9%, respectively, in the CYP2C19 poor metabolizers compared with the homozygous extensive metabolizers. The CLB clearance was 44% higher in subjects homozygous for the POR*28 T allele than in those homozygous for the POR*28 C allele, although the genotypes did not affect the N-CLB clearance. The concomitant use of phenobarbital, phenytoin, and zonisamide significantly affected the CLB clearance, whereas that of carbamazepine, phenytoin, and valproic acid affected the N-CLB clearance. The weight also significantly influenced the CLB clearance and volume of distribution of both CLB and N-CLB.Our results showed that the CYP2C19 and/or POR genotypes have an impact on the CLB and/or N-CLB clearance. These results suggest that determining the CYP2C19 and/or POR genotypes is helpful for obtaining appropriate serum CLB and N-CLB concentrations and preventing an overdose when starting CLB therapy." @default.
- W2092952604 created "2016-06-24" @default.
- W2092952604 creator A5003077616 @default.
- W2092952604 creator A5005900553 @default.
- W2092952604 creator A5015782642 @default.
- W2092952604 creator A5019101049 @default.
- W2092952604 creator A5021805738 @default.
- W2092952604 creator A5045525134 @default.
- W2092952604 creator A5047027191 @default.
- W2092952604 creator A5047227710 @default.
- W2092952604 creator A5054737120 @default.
- W2092952604 creator A5080239077 @default.
- W2092952604 creator A5081164979 @default.
- W2092952604 creator A5088581964 @default.
- W2092952604 creator A5091805117 @default.
- W2092952604 date "2014-06-01" @default.
- W2092952604 modified "2023-10-01" @default.
- W2092952604 title "Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy" @default.
- W2092952604 cites W1983073359 @default.
- W2092952604 cites W1989897414 @default.
- W2092952604 cites W1995878239 @default.
- W2092952604 cites W2003957180 @default.
- W2092952604 cites W2006557600 @default.
- W2092952604 cites W2022895457 @default.
- W2092952604 cites W2024868771 @default.
- W2092952604 cites W2027852910 @default.
- W2092952604 cites W2027973603 @default.
- W2092952604 cites W2035250071 @default.
- W2092952604 cites W2037219647 @default.
- W2092952604 cites W2041379086 @default.
- W2092952604 cites W2043645215 @default.
- W2092952604 cites W2060587811 @default.
- W2092952604 cites W2062351103 @default.
- W2092952604 cites W2071072708 @default.
- W2092952604 cites W2080240185 @default.
- W2092952604 cites W2080962580 @default.
- W2092952604 cites W2082818506 @default.
- W2092952604 cites W2090540550 @default.
- W2092952604 cites W2103836675 @default.
- W2092952604 cites W2118686382 @default.
- W2092952604 cites W2134634156 @default.
- W2092952604 cites W2154310483 @default.
- W2092952604 cites W2159241839 @default.
- W2092952604 cites W4211087970 @default.
- W2092952604 doi "https://doi.org/10.1097/ftd.0000000000000015" @default.
- W2092952604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24345815" @default.
- W2092952604 hasPublicationYear "2014" @default.
- W2092952604 type Work @default.
- W2092952604 sameAs 2092952604 @default.
- W2092952604 citedByCount "47" @default.
- W2092952604 countsByYear W20929526042014 @default.
- W2092952604 countsByYear W20929526042015 @default.
- W2092952604 countsByYear W20929526042016 @default.
- W2092952604 countsByYear W20929526042017 @default.
- W2092952604 countsByYear W20929526042018 @default.
- W2092952604 countsByYear W20929526042020 @default.
- W2092952604 countsByYear W20929526042021 @default.
- W2092952604 countsByYear W20929526042022 @default.
- W2092952604 countsByYear W20929526042023 @default.
- W2092952604 crossrefType "journal-article" @default.
- W2092952604 hasAuthorship W2092952604A5003077616 @default.
- W2092952604 hasAuthorship W2092952604A5005900553 @default.
- W2092952604 hasAuthorship W2092952604A5015782642 @default.
- W2092952604 hasAuthorship W2092952604A5019101049 @default.
- W2092952604 hasAuthorship W2092952604A5021805738 @default.
- W2092952604 hasAuthorship W2092952604A5045525134 @default.
- W2092952604 hasAuthorship W2092952604A5047027191 @default.
- W2092952604 hasAuthorship W2092952604A5047227710 @default.
- W2092952604 hasAuthorship W2092952604A5054737120 @default.
- W2092952604 hasAuthorship W2092952604A5080239077 @default.
- W2092952604 hasAuthorship W2092952604A5081164979 @default.
- W2092952604 hasAuthorship W2092952604A5088581964 @default.
- W2092952604 hasAuthorship W2092952604A5091805117 @default.
- W2092952604 hasConcept C104317684 @default.
- W2092952604 hasConcept C109650736 @default.
- W2092952604 hasConcept C112705442 @default.
- W2092952604 hasConcept C118552586 @default.
- W2092952604 hasConcept C126322002 @default.
- W2092952604 hasConcept C135763542 @default.
- W2092952604 hasConcept C140840227 @default.
- W2092952604 hasConcept C185592680 @default.
- W2092952604 hasConcept C2777477808 @default.
- W2092952604 hasConcept C2777907850 @default.
- W2092952604 hasConcept C2778186239 @default.
- W2092952604 hasConcept C2908647359 @default.
- W2092952604 hasConcept C526171541 @default.
- W2092952604 hasConcept C55493867 @default.
- W2092952604 hasConcept C55775858 @default.
- W2092952604 hasConcept C62231903 @default.
- W2092952604 hasConcept C71924100 @default.
- W2092952604 hasConcept C98274493 @default.
- W2092952604 hasConcept C99454951 @default.
- W2092952604 hasConceptScore W2092952604C104317684 @default.
- W2092952604 hasConceptScore W2092952604C109650736 @default.
- W2092952604 hasConceptScore W2092952604C112705442 @default.
- W2092952604 hasConceptScore W2092952604C118552586 @default.
- W2092952604 hasConceptScore W2092952604C126322002 @default.
- W2092952604 hasConceptScore W2092952604C135763542 @default.